Oct 31, 2018 7:00am EDT Tonix Pharmaceuticals Announces Innovative Design in Next Phase 3 Study of Tonmya® for PTSD, Following FDA Meeting
Oct 29, 2018 7:00am EDT Tonix Pharmaceuticals will Present Phase 3 HONOR and Phase 2 AtEase Study Results in Poster Presentations at CNS Summit 2018
Oct 23, 2018 7:00am EDT Tonix Pharmaceuticals to Present at the Dawson James Securities Small Cap Growth Conference
Sep 20, 2018 7:00am EDT Tonix Pharmaceuticals to Present at Sidoti & Company Fall 2018 Investor Conference
Aug 21, 2018 7:00am EDT Tonix Pharmaceuticals Presents Results and Retrospective Analyses of Two Double-Blind, Randomized Placebo-Controlled 12-Week Studies of Tonmya® in Military-Related PTSD at the 2018 Military Health System Research Symposium
Aug 15, 2018 11:46am EDT Tonix Pharmaceuticals will Present Phase 3 HONOR and Phase 2 AtEase Study Results in a Poster Presentation at the 2018 Military Health System Research Symposium